Chemed Corporation
CHENYSECIK 19584Healthcare / Healthcare Providers & Servicesfiscal year ends December70 quarters since 2009
Latest quarter Q3 FY2026, filed October 29, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.
Share price
Daily candlesticks from November 18, 2024 to November 13, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.
The last 16 quarters
Q4 FY2022 to Q3 FY2026, through the filing of October 29, 2026.
Net income losses drawn in red.
Operating cash flow less capital expenditures; negative quarters in red.
Positions at each quarter end, as filed; short-term investments are not included.
Income statement
Last eight quarters, newest first, through Q3 FY2026 filed October 29, 2026.
| Millions of dollars | Q3 FY2026ended Sep 30, 2026filed Oct 29, 2026 | Q2 FY2026ended Jun 30, 2026filed Jul 31, 2026 | Q1 FY2026ended Mar 31, 2026filed Apr 28, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 27, 2026 | Q3 FY2025ended Sep 30, 2025filed Oct 31, 2025 | Q2 FY2025ended Jun 30, 2025filed Jul 31, 2025 | Q1 FY2025ended Mar 31, 2025filed Apr 28, 2025 | Q4 FY2024ended Dec 31, 2024filed Feb 28, 2025 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 691 | 673 | 658 | 639 | 625 | 619 | 647 | 640 | +10.6% |
| Cost of revenue | 458 | 452 | 442 | 417 | 425 | 434 | 431 | 406 | +7.7% |
| Gross profit | — | — | — | — | — | — | — | — | — |
| Research and development | — | — | — | — | — | — | — | — | — |
| Selling, general and administrative | 111 | 115 | 114 | 106 | 106 | 100 | 106 | 104 | +5.4% |
| Operating income | 96 | 89 | 85 | 101 | 75 | 68 | 95 | 114 | +29.0% |
| Other income (expense) | 2 | 4 | 5 | 5 | 9 | 3 | 1 | 7 | −74.2% |
| Pretax income | 97 | 91 | 89 | 105 | 84 | 71 | 96 | 120 | +15.8% |
| Income tax | 25 | 24 | 23 | 29 | 19 | 19 | 24 | 30 | +29.8% |
| Net income | 72 | 68 | 66 | 77 | 64 | 52 | 72 | 90 | +11.5% |
| Diluted EPS ($) | 5.45 | 5.13 | 4.84 | — | 4.46 | 3.57 | 4.86 | — | +22.2% |
| Diluted shares (millions) | 13 | 13 | 14 | — | 14 | 15 | 15 | — | — |
Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.
Balance sheet
Last eight quarters, newest first, through Q3 FY2026 filed October 29, 2026.
| Millions of dollars | Q3 FY2026ended Sep 30, 2026filed Oct 29, 2026 | Q2 FY2026ended Jun 30, 2026filed Jul 31, 2026 | Q1 FY2026ended Mar 31, 2026filed Apr 28, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 27, 2026 | Q3 FY2025ended Sep 30, 2025filed Oct 31, 2025 | Q2 FY2025ended Jun 30, 2025filed Jul 31, 2025 | Q1 FY2025ended Mar 31, 2025filed Apr 28, 2025 | Q4 FY2024ended Dec 31, 2024filed Feb 28, 2025 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 48 | 40 | 17 | 75 | 130 | 250 | 174 | 178 | −62.7% |
| Short-term investments | — | — | — | — | — | — | — | — | — |
| Total current assets | 366 | 291 | 274 | 303 | 395 | 491 | 502 | 395 | −7.5% |
| Total assets | 1,718 | 1,580 | 1,536 | 1,538 | 1,624 | 1,718 | 1,727 | 1,669 | +5.8% |
| Total current liabilities | 331 | 320 | 321 | 287 | 292 | 264 | 291 | 286 | +13.3% |
| Long-term debt | 236 | 140 | 91 | — | — | — | — | — | — |
| Total debt | 236 | 140 | 91 | — | — | — | — | — | — |
| Total liabilities | 857 | 749 | 688 | 559 | 547 | 519 | 545 | 550 | +56.7% |
| Stockholders’ equity | 861 | 831 | 848 | 979 | 1,077 | 1,198 | 1,182 | 1,119 | −20.0% |
| Shares outstanding (millions) | 13 | 13 | 13 | 14 | 14 | 15 | 15 | 15 | — |
Positions at each period end. Long-term debt is the line the filer tags, with or without its current portion. Total debt is one definition across filers, built from filed lines: long-term debt with its current portion plus short-term borrowings, finance leases where the filer folds them into its debt line, operating leases never; it is blank where the tags do not add up to it. Italic figures are derived.
Cash flow statement
Last eight quarters, newest first, through Q3 FY2026 filed October 29, 2026.
| Millions of dollars | Q3 FY2026ended Sep 30, 2026filed Oct 29, 2026 | Q2 FY2026ended Jun 30, 2026filed Jul 31, 2026 | Q1 FY2026ended Mar 31, 2026filed Apr 28, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 27, 2026 | Q3 FY2025ended Sep 30, 2025filed Oct 31, 2025 | Q2 FY2025ended Jun 30, 2025filed Jul 31, 2025 | Q1 FY2025ended Mar 31, 2025filed Apr 28, 2025 | Q4 FY2024ended Dec 31, 2024filed Feb 28, 2025 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 57 | 85 | 88 | 134 | 83 | 139 | 33 | 165 | −32.1% |
| Capital expenditures | 19 | 16 | 17 | 16 | 17 | 16 | 13 | withheld | +7.0% |
| Free cash flow (CFO − capex) | 38 | 69 | 71 | 117 | 66 | 123 | 19 | — | −42.5% |
| Depreciation and amortization | 17 | 17 | 17 | 16 | 16 | 16 | 16 | 16 | +7.2% |
| Share repurchases | 63 | 97 | 190 | 175 | 181 | 43 | 33 | 209 | −65.4% |
| Dividends paid | 9 | 8 | 8 | 8 | 9 | 7 | 7 | 7 | +6.1% |
10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.
Annual statements
Every fiscal year filed, newest first, through FY2025 filed February 27, 2026.
Income statement
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 27, 2026 | FY2024ended Dec 31, 2024filed Feb 28, 2025 | FY2023ended Dec 31, 2023filed Feb 29, 2024 | FY2022ended Dec 31, 2022filed Feb 27, 2023 | FY2021ended Dec 31, 2021filed Feb 28, 2022 | FY2020ended Dec 31, 2020filed Feb 26, 2021 | FY2019ended Dec 31, 2019filed Feb 26, 2020 | FY2018ended Dec 31, 2018filed Feb 27, 2019 | FY2017ended Dec 31, 2017filed Feb 26, 2018 | FY2016ended Dec 31, 2016filed Feb 27, 2017 | FY2015ended Dec 31, 2015filed Feb 26, 2016 | FY2014ended Dec 31, 2014filed Feb 27, 2015 | FY2013ended Dec 31, 2013filed Feb 27, 2014 | FY2012ended Dec 31, 2012filed Feb 27, 2013 | FY2011ended Dec 31, 2011filed Feb 27, 2012 | FY2010ended Dec 31, 2010filed Feb 28, 2011 | FY2009ended Dec 31, 2009filed Jul 30, 2010 | FY2008ended Dec 31, 2008filed Jul 30, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,530 | 2,431 | 2,264 | 1,202 | 1,261 | 1,335 | 1,281 | 1,198 | 1,667 | 1,577 | 1,543 | 1,456 | 1,413 | 1,430 | 1,356 | 1,281 | 1,190 | 1,149 |
| Cost of revenue | 1,707 | 1,577 | 1,466 | 1,370 | 1,369 | 1,378 | 1,321 | 1,228 | 1,151 | 1,115 | 1,088 | 1,035 | 1,009 | 1,033 | 970 | 906 | 835 | 811 |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Research and development | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Selling, general and administrative | 417 | 424 | 395 | 359 | 367 | 330 | 306 | 271 | 277 | 244 | 238 | 223 | 216 | 209 | 202 | 202 | 197 | 175 |
| Operating income | 338 | 366 | 341 | 343 | 343 | 390 | 257 | 244 | 113 | 179 | 184 | 168 | 133 | 156 | 154 | 144 | 126 | 133 |
| Other income (expense) | 19 | 35 | 13 | (9) | 9 | 9 | 9 | 1 | 8 | 2 | (1) | 3 | 5 | 4 | 1 | 2 | 6 | (9) |
| Pretax income | 356 | 399 | 350 | 330 | 350 | 396 | 262 | 240 | 117 | 177 | 180 | 163 | 124 | 146 | 141 | 134 | 121 | 115 |
| Income tax | 91 | 97 | 78 | 80 | 82 | 77 | 42 | 34 | 19 | 68 | 70 | 63 | 47 | 57 | 55 | 52 | 47 | 47 |
| Net income | 265 | 302 | 273 | 250 | 269 | 319 | 220 | 206 | 98 | 109 | 110 | 99 | 77 | 89 | 86 | 82 | 74 | 67 |
| Diluted EPS ($) | 18.34 | 19.89 | 17.93 | 16.53 | 16.85 | 19.48 | 13.31 | 12.23 | 5.86 | 6.48 | 6.33 | 5.57 | 4.16 | 4.62 | 4.10 | 3.55 | 3.24 | 2.88 |
| Diluted shares (millions) | 14 | 15 | 15 | 15 | 16 | 16 | 17 | 17 | 17 | 17 | 17 | 18 | 19 | 19 | 21 | 23 | 23 | 23 |
Balance sheet
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 27, 2026 | FY2024ended Dec 31, 2024filed Feb 28, 2025 | FY2023ended Dec 31, 2023filed Feb 29, 2024 | FY2022ended Dec 31, 2022filed Feb 27, 2023 | FY2021ended Dec 31, 2021filed Feb 28, 2022 | FY2020ended Dec 31, 2020filed Feb 26, 2021 | FY2019ended Dec 31, 2019filed Feb 26, 2020 | FY2018ended Dec 31, 2018filed Feb 27, 2019 | FY2017ended Dec 31, 2017filed Feb 26, 2018 | FY2016ended Dec 31, 2016filed Feb 27, 2017 | FY2015ended Dec 31, 2015filed Feb 26, 2016 | FY2014ended Dec 31, 2014filed Feb 27, 2015 | FY2013ended Dec 31, 2013filed Feb 27, 2014 | FY2012ended Dec 31, 2012filed Feb 27, 2013 | FY2011ended Dec 31, 2011filed Feb 27, 2012 | FY2010ended Dec 31, 2010filed Feb 28, 2011 | FY2009ended Dec 31, 2009filed Jul 30, 2010 | FY2008ended Dec 31, 2008filed Jul 30, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 75 | 178 | 264 | 74 | 33 | 163 | 6 | 5 | 11 | 15 | 15 | 14 | 84 | 70 | 38 | 50 | 112 | 4 |
| Short-term investments | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total current assets | 303 | 395 | 501 | 273 | 230 | 329 | 191 | 160 | 176 | 170 | 151 | 175 | 225 | 198 | 151 | 197 | 198 | — |
| Total assets | 1,538 | 1,669 | 1,668 | 1,442 | 1,343 | 1,435 | 1,268 | 976 | 920 | 880 | 852 | 860 | 894 | 860 | 796 | 830 | 819 | — |
| Total current liabilities | 287 | 286 | 312 | 297 | 302 | 299 | 262 | 192 | 194 | 172 | 171 | 176 | 364 | 157 | 145 | 149 | 136 | — |
| Long-term debt | — | — | — | 93 | 185 | — | 90 | 89 | 91 | 100 | 84 | 141 | 184 | 175 | 167 | 159 | 152 | — |
| Total debt | — | — | — | 98 | 185 | — | 90 | 89 | 101 | 109 | 91 | 148 | 184 | 175 | 167 | 159 | 152 | — |
| Total liabilities | 559 | 550 | 560 | 643 | 719 | 534 | 542 | 384 | 380 | 356 | 339 | 409 | 445 | 406 | 382 | 368 | 342 | — |
| Stockholders’ equity | 979 | 1,119 | 1,108 | 799 | 623 | 901 | 727 | 591 | 540 | 524 | 513 | 451 | 449 | 453 | 414 | 462 | 477 | — |
| Shares outstanding (millions) | 14 | 15 | 15 | 15 | 15 | 16 | 16 | 16 | 16 | 16 | 17 | 17 | 18 | 19 | 19 | 21 | — | — |
Cash flow statement
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 27, 2026 | FY2024ended Dec 31, 2024filed Feb 28, 2025 | FY2023ended Dec 31, 2023filed Feb 29, 2024 | FY2022ended Dec 31, 2022filed Feb 27, 2023 | FY2021ended Dec 31, 2021filed Feb 28, 2022 | FY2020ended Dec 31, 2020filed Feb 26, 2021 | FY2019ended Dec 31, 2019filed Feb 26, 2020 | FY2018ended Dec 31, 2018filed Feb 27, 2019 | FY2017ended Dec 31, 2017filed Feb 26, 2018 | FY2016ended Dec 31, 2016filed Feb 27, 2017 | FY2015ended Dec 31, 2015filed Feb 26, 2016 | FY2014ended Dec 31, 2014filed Feb 27, 2015 | FY2013ended Dec 31, 2013filed Feb 27, 2014 | FY2012ended Dec 31, 2012filed Feb 27, 2013 | FY2011ended Dec 31, 2011filed Feb 27, 2012 | FY2010ended Dec 31, 2010filed Feb 28, 2011 | FY2009ended Dec 31, 2009filed Jul 30, 2010 | FY2008ended Dec 31, 2008filed Jul 30, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 388 | 417 | 330 | 310 | 309 | 489 | 301 | 287 | 162 | 135 | 172 | — | — | 132 | 174 | 86 | 161 | 112 |
| Capital expenditures | 63 | 50 | 57 | 57 | 59 | 59 | 53 | 53 | 64 | 40 | 44 | 44 | 29 | 35 | 30 | 26 | 21 | 26 |
| Free cash flow (CFO − capex) | 325 | 368 | 273 | 253 | 250 | 430 | 248 | 234 | 98 | 96 | 127 | — | — | 97 | 145 | 60 | 139 | 86 |
| Depreciation and amortization | 65 | 63 | 61 | 59 | 59 | 57 | 45 | 39 | 36 | 35 | 33 | 31 | 29 | 28 | 27 | 26 | 26 | — |
| Share repurchases | 432 | 361 | 68 | 115 | 576 | 176 | 93 | 159 | 95 | 102 | 59 | 110 | 93 | 61 | 144 | 109 | 1 | 67 |
| Dividends paid | 32 | 27 | 24 | 22 | 22 | 21 | 20 | 19 | 17 | 16 | 16 | 14 | 14 | 13 | 13 | 12 | 8 | 6 |
Insider activity
Form 4 filings by officers, directors and 10% owners, November 16, 2024 to November 16, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.
The last 25 transactions
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | Lee Spencer S | executive vice president | gift | 60 | $0.00 | — | 12,871 | Nov 16, 2026 |
| Nov 11, 2026 | Lee Spencer S | executive vice president | open-market sale | 1,000 | $547.61 | $548K | 12,931 | Nov 13, 2026 |
| Nov 3, 2026 | Mcnamara Kevin J | president and CEO, Director | open-market sale | 2,000 | $537.90 | $1M | 82,220 | Nov 5, 2026 |
| Nov 2, 2026 | Lee Spencer S | executive vice president | open-market sale | 920 | $537.17 | $494K | 13,931 | Nov 3, 2026 |
| Sep 30, 2026 | Lee Spencer S | executive vice president | option exercise | 12,099 | $445.35 | $5M | 26,011 | Oct 1, 2026 |
| Sep 30, 2026 | Lee Spencer S | executive vice president | tax withholding | 11,160 | $508.93 | $6M | 14,851 | Oct 1, 2026 |
| Sep 28, 2026 | Mcnamara Kevin J | president and CEO, Director | open-market sale | 2,000 | $513.45 | $1M | 66,418 | Sep 30, 2026 |
| Sep 28, 2026 | Hutton Thomas C | vice president, Director | option exercise | 4,629 | $445.35 | $2M | 37,110 | Sep 29, 2026 |
| Sep 28, 2026 | Hutton Thomas C | vice president, Director | tax withholding | 4,270 | $506.65 | $2M | 32,840 | Sep 29, 2026 |
| Sep 18, 2026 | Mcnamara Kevin J | president and CEO, Director | open-market sale | 2,000 | $501.40 | $1M | 68,418 | Sep 21, 2026 |
| Aug 21, 2026 | Lee Spencer S | executive vice president | open-market sale | 1,000 | $541.04 | $541K | 13,912 | Aug 24, 2026 |
| Aug 21, 2026 | Mcnamara Kevin J | president and CEO, Director | open-market sale | 2,000 | $541.16 | $1M | 70,418 | Aug 24, 2026 |
| Aug 10, 2026 | Judkins Brian C | VP and Chief Legal Officer | option exercise | 6,786 | $445.35 | $3M | 9,222 | Aug 10, 2026 |
| Aug 10, 2026 | Judkins Brian C | VP and Chief Legal Officer | tax withholding | 5,878 | $548.96 | $3M | 3,344 | Aug 10, 2026 |
| Aug 5, 2026 | Wherley Joel L | CEO - Vitas Healthcare | option exercise | 2,599 | $445.35 | $1M | 3,451 | Aug 6, 2026 |
| Aug 5, 2026 | Wherley Joel L | CEO - Vitas Healthcare | tax withholding | 2,270 | $542.62 | $1M | 1,181 | Aug 6, 2026 |
| Aug 3, 2026 | Mcnamara Kevin J | president and CEO, Director | open-market sale | 2,000 | $539.51 | $1M | 70,418 | Aug 4, 2026 |
| Jul 31, 2026 | Mcnamara Kevin J | president and CEO, Director | option exercise | 2,001 | $445.35 | $891K | 92,220 | Aug 4, 2026 |
| Jul 31, 2026 | Mcnamara Kevin J | president and CEO, Director | tax withholding | 19,802 | $529.22 | $10M | 72,418 | Aug 4, 2026 |
| Jul 31, 2026 | Grace Patrick P | Director | open-market sale | 190 | $532.00 | $101K | 3,533 | Aug 3, 2026 |
| Jun 9, 2026 | Lindell Andrea R | Director | open-market sale | 1,347 | $447.33 | $603K | 4,578 | Jun 10, 2026 |
| May 29, 2026 | Walsh George J III | Director | open-market sale | 500 | $437.83 | $219K | 3,209 | May 29, 2026 |
| May 18, 2026 | Walsh George J III | Director | award | 386 | $440.77 | $170K | 3,709 | May 19, 2026 |
| May 18, 2026 | Mount John Meredith Jr. | Director | award | 386 | $440.77 | $170K | 1,316 | May 19, 2026 |
| May 18, 2026 | McCarthy Eileen P | Director | award | 386 | $440.77 | $170K | 1,241 | May 19, 2026 |
Full insider history for Chemed Corporation, or insider activity across all companies. A record of filings, not a recommendation.
Tracked funds holding it
1 of the tracked managers held CHE in their latest 13F filing, through November 12, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded CHE by quarter.
| Fund | Manager | Quarter | Value | Shares | Weight | Move |
|---|---|---|---|---|---|---|
| Renaissance Technologies | Peter Brown | Q3 2026 | $20M | 38,680 | 0.03% | held −1.0% |
Sources
Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.
- Filer
- CHEMED CORPORATION, CIK 19584 on EDGAR
- Extract generated
- November 16, 2026
- Withheld
- 1 line-years whose four quarters do not sum to the filed year: capex FY2024
- Repaired
- 2 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: other income FY2018, capex FY2024
XBRL concepts behind each line
Income statement
RevenueFromContractWithCustomerExcludingAssessedTax, Revenues, SalesRevenueNetCostOfGoodsAndServicesSold, CostOfRevenueSellingGeneralAndAdministrativeExpenseOperatingIncomeLossNonoperatingIncomeExpense, OtherNonoperatingIncomeExpenseIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsIncomeTaxExpenseBenefitNetIncomeLossEarningsPerShareDilutedWeightedAverageNumberOfDilutedSharesOutstandingBalance sheet
CashAndCashEquivalentsAtCarryingValueAssetsCurrentAssetsLiabilitiesCurrentLongTermDebt, LongTermDebtNoncurrentLongTermDebt, noncurrentLiabilitiesStockholdersEquitydei:EntityCommonStockSharesOutstandingCash flow statement
NetCashProvidedByUsedInOperatingActivitiesPaymentsToAcquireProductiveAssets, PaymentsToAcquirePropertyPlantAndEquipmentDepreciationDepletionAndAmortizationPaymentsForRepurchaseOfCommonStockPaymentsOfDividendsCommonStockThe data
The statements on this page as files, generated November 16, 2026.
- JSON file
/data/financials/CHE.json